CrushSCI.com
184Average days
168Median days
28Fastest days
368Longest days
1,0312025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

157 days

Deubiquitination of C/EBPβ by FAM63A mediates resistance to glutaminolysis inhibition in MYC-amplified hepatocellular carcinoma

Authors
Zhouyu Lv; Juan Cao; Yiying Qu; Feng xu; Song Gao; Zhixin Deng; Jialin Fu; Yajun Zhao; Jintao Guo; Siyu Sun; Yang LiuShow moreShow less
Affiliations
1. Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China; 2. Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China; 3. Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China; 4. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, ChinaShow moreShow less
Source PDF DOI Publisher page
368 days

FDX1-mediated disulfidptosis drives progression of sepsis-associated AKI

Authors
Han Li; Hongjun Miao; Haonan Wang; Yingjie Fu; Yali Qian; Jiangwen Yin; Xin Zhong; Aihua Zhang; Jia Fu; Xuhua GeShow moreShow less
Affiliations
1. Department of Emergency/Critical Medicine, Children’s Hospital of Nanjing Medical University, Nanjing, China; 2. Jiangsu Key Laboratory of Children’s Major Disease Research, Nanjing, China; 3. Nanjing Children’s Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing, China; 4. Department of Nephrology, Children’s Hospital of Nanjing Medical University, Nanjing, China; 5. Icahn School of Medicine at Mount Sinai, New York, USAShow moreShow less
Source PDF DOI Publisher page
176 days

Matrix stiffness drives early OSCC metastasis by inducing a PERK-dependent unfolded protein response

Authors
Kan Li; Qiuhan Zheng; Hong Jiang; Jianghai Chen; Jingyuan Li; Huanzi Lu; Yahui Wang; Dikan Wang; Gao Zhang; Zhenyu Yang; Zhen Zeng; Guiqing Liao; Yujie LiangShow moreShow less
Affiliations
1. Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China; 2. Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou, China; 3. Faculty of Dentistry, the University of Hong Kong, Hong Kong, China; 4. Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, ChinaShow moreShow less
Source PDF DOI Publisher page
183 days

Deubiquitinase USP14 restrains autophagy via LARS/mTORC1 axis to accelerate apoptosis in intervertebral disc degeneration

Authors
Dageng Huang; Yanmin Chang; Bin Gui; Yanming Ma; Xingyu Zhou; Huaizhen Liang; Shuai Li; Yu Song; Renfeng Liu; Hailiang Xu; Hui Li; Youjun Liu; Weidong Wu; Zhiyuan Wang; Cheng Ju; Cao Yang; Ming Zhang; Shuaijun Jia; Lei Zhu; Rongjin LuoShow moreShow less
Affiliations
1. Department of Spine Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China; 2. Shaanxi Key Laboratory of Spine Bionic Treatment, Xi’an, China; 3. Honghui Hospital, Xi’an Jiaotong University, Xi’an, China; 4. Department of Nuclear Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an,, China; 5. Graduate School, Shaanxi University of Chinese Medicine, Xianyang, China; 6. Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 7. Department of Medical Imaging, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaShow moreShow less
Source PDF DOI Publisher page
274 days

Combining inhaled hyperoxia and olaparib for treating lung metastases in uveal and cutaneous melanoma

Authors
Ana Belén Herrera-Campos; Daniel Delgado-Bellido; Estefanía Arias-Torres; Francisco O’Valle; Natividad Martín-Morales; Laura Montosa-Hidalgo; Esteban Zamudio-Martínez; José Manuel Rodríguez-Vargas; Alberto Pascual; Raheleh Rahbari; F. Javier Oliver; Angel Garcia-DiazShow moreShow less
Affiliations
1. Institute of Parasitology and Biomedicine López Neyra, CSIC, Granada, Spain; 2. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain; 3. Faculty of Medicine, Department of Pathology, University of Granada (UGR), Granada, Spain; 4. Faculty of Science, Department of Cell Biology, University of Granada (UGR), Granada, Spain; 5. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain; 6. Cancer, Ageing and Somatic Mutation (CASM), Wellcome Trust Sanger Institute, Cambridge, UK; 7. Research Unit “Modeling Nature” (MNat), Universidad de Granada, Granada, SpainShow moreShow less
Source PDF DOI Publisher page
129 days

HIPK2-and IKKβ-dependent phosphorylation stabilizes TAp63α during the oocyte DNA damage response

Authors
Anjali Kumari; Kiran Kumar P; Akshay Kumar; Aradhana Mohanty; Abhilasha S; Lava Kumar S; Ajith Kumar E; Athar Mohd; Pravin Birajdar; Silambresan. Y; Sahina Sabnam; Ravi Kiran Putchala; R. Yelagandula; H. B. D. Prasada RaoShow moreShow less
Affiliations
1. BRIC-National Institute of Animal Biotechnology, Hyderabad, India; 2. Regional Centre for Biotechnology, Faridabad, India; 3. BRIC-Centre for DNA Fingerprinting and Diagnostics, Hyderabad, IndiaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Cell Death & Disease take to review a manuscript?

As of 2026-11-18, CrushSCI has 20 complete review records for Cell Death & Disease. The fastest paper went from submission to acceptance in 28 days (Loss of Atp8a2 drives neurodegeneration through the dysregulation of spatiotemporal phosphatidylserine externalization in mature neurons, received 2026-06-01, accepted 2026-06-29); the slowest took 368 days. The average is 184 days and the median is 168 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.